Get the latest news from the biopharma and related fields

We know how busy your days are. So, we offer you a weekly dose of content related to logistics, clinical trials, health, and medicine.

First of all, if you need some small talk material today, we have got you covered:

· PAXLOVID™ reduced the risk of hospitalization or death by 89% (within three days of symptom onset) and 88% (within five days of symptom onset) compared to placebo.

· Three shots of the Sinovac vaccine show a 94% neutralizing antibody positive rate against Omicron.

· Improving clinical trial diversity should be the industry’s top priority for the next five years.

Also, see some news that caught our eye this week.

Huston, we have a problem. It’s called a replication test. It is the most critical issue that every researcher fears, like the plague.

And it seems that we face this issue in cancer research. Data reports that out of 193 experiments conducted from 2010 to 2012, only 50 experiments can be repeated. What does it mean? Want to know more

Can you imagine how much data related to health has accumulated now? There are plenty of wearables, electronic patient-reported outcomes (ePRO), electronic clinical outcome assessments (eCOA), electronic informed consents (eICF), etc. The list is endless. That's terabytes of data! Know how we can use it!

Is aging a disease or a natural process? What do you think? What if scientists have found a way, we can extend the human lifespan. If so, can aging really be 'treated' or 'cured?

It seems that we are at the threshold of discovery. A new 'anti-aging' vaccine successfully extended the life of rodents by destroying senescent cells. It’s not a joke. Read now!

Ok, that’s all for now. If you want to catch up with the news as it happens, follow us on Telegram or say hi on Facebook!

See you next week!